tetradecanoylphorbol acetate has been researched along with bortezomib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TP; Sanacora, S; Vancurova, I | 1 |
Angiolillo, C; Cirone, M; D'Orazi, G; Faggioni, A; Gilardini Montani, MS; Granato, M | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and bortezomib
Article | Year |
---|---|
Chromatin immunoprecipitation analysis of bortezomib-mediated inhibition of NFκB recruitment to IL-1β and TNFα gene promoters in human macrophages.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Chromatin Immunoprecipitation; Humans; Interleukin-1beta; Lipopolysaccharides; Macrophages; NF-kappa B; Promoter Regions, Genetic; Pyrazines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2014 |
Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.
Topics: Antineoplastic Agents; Bortezomib; Butyric Acid; Cell Line, Tumor; Down-Regulation; Heat Shock Transcription Factors; Herpesvirus 8, Human; Humans; Metformin; NF-E2-Related Factor 2; Quercetin; Reactive Oxygen Species; RNA-Binding Proteins; Sequestosome-1 Protein; Tetradecanoylphorbol Acetate; Trans-Activators; Transcriptional Activation; Virus Activation; Virus Latency | 2018 |